AQP4 and myeloid sarcoma: Although a majority of studies find sGFAP to be significantly higher in AQP4-IgG-positive NMOSD compared to MS, there is overlap in the concentrations reported, and therefore no validated numeric sGFAP cutoff has been universally established to support NMOSD diagnosis.